FDA Food recall F-0721-2022
Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY
- FDA Food
- Class II
- terminated
- Published 2022-02-16
On 2022-02-16 the FDA classified a Class II recall of Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY by Ultratab Laboratories, citing cGMP Deviations.
Read the official FDA Food notice
| Agency | FDA Food |
|---|---|
| Recall number | F-0721-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-10-06 |
| Published | 2022-02-16 |
| Last updated | 2026-09-13 11:50 UTC |
| Company | Ultratab Laboratories |
| Distribution | FL, NY |
Product
Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY
Reason
cGMP Deviations
Identifiers
| code_info | Product Codes: M943 M943L Bulk Lots: 16K038, 18B075 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:50 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-0721-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.